
Emerging Trends in Gene Therapy: Thalassemia as a Case Study
CDC Seminar— June 22, 2023, 2:00–3:00 PM ET
Human embryo science: can the world’s regulators keep pace? Concerned by the speed of research, policymakers are looking for alternative ways to establish rules on genome editing and other technologies.
P Ball, Nature, May 10, 2023
The ethics, equity, and governance of human genome editing need greater consideration.
Sarojini Nadimpally et al. BMJ 2023 5 p996
In the business of base editors: Evolution from bench to bedside.
Elizabeth M Porto et al. PLoS Biol 2023 4 (4) e3002071
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:May 31, 2023
- Content source: